Press release
Global Prosthetic Heart Valves Market to grow at a CAGR of 11.86% by 2032, Evaluates DelveInsight
DelveInsight's "Prosthetic Heart Valves Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Prosthetic Heart Valves companies actively working in the market.
To know more about why North America is leading the market growth in the Prosthetic Heart Valves market, get a snapshot of the report Prosthetic Heart Valves Market Trends
https://www.delveinsight.com/sample-request/prosthetic-heart-valve-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Prosthetic Heart Valves Overview
Prosthetic heart valves are artificial devices implanted in the heart to replace damaged or diseased natural valves that fail to function properly. They help maintain normal blood flow and prevent backflow within the heart. These valves are typically classified into two main types: mechanical valves, made from durable materials like titanium or carbon, and biological (tissue) valves, derived from animal or human tissue. Prosthetic heart valves are commonly used to treat conditions such as valvular stenosis or regurgitation, improving cardiac efficiency and overall patient survival.
DelveInsight Analysis: The global prosthetic heart valve market size is projected to expand at a compound annual growth rate (CAGR) of approximately 11.86% between 2025 and 2032.
Prosthetic Heart Valves Market Insights
Geographically, North America is projected to hold the largest share of the global prosthetic heart valves market in 2024. This dominance is primarily driven by the region's advanced healthcare infrastructure, high burden of cardiovascular diseases, and growing adoption of minimally invasive surgical procedures. Strong research and development efforts have led to the creation of innovative valve materials and designs, improving patient outcomes and treatment efficiency. Moreover, favorable reimbursement frameworks, an expanding aging population susceptible to valve disorders, and the presence of leading industry players further strengthen the region's leadership. In addition, increasing awareness and early diagnosis through extensive screening programs continue to support market growth across North America.
To read more about the latest highlights related to Prosthetic Heart Valves, get a snapshot of the key highlights entailed in the Prosthetic Heart Valves Market Insights
https://www.delveinsight.com/report-store/prosthetic-heart-valve-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Prosthetic Heart Valves Market Report
• In February 2024, Edwards Lifesciences Corporation introduced the EVOQUE tricuspid valve replacement system as the first transcatheter therapy approved by the U.S. Food and Drug Administration (FDA) for treating tricuspid regurgitation (TR).
• In March 2022, Edwards Lifesciences announced that it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.
• Thus, owing to such developments in the market, rapid growth will be observed in the Prosthetic Heart Valves market during the forecast period
Key Players in the Prosthetic Heart Valves Market
Some of the key market players operating in the Prosthetic Heart Valves market include- Medtronic plc., Abott., Edwards Lifesciences Corp., Corcym Srl, Boston Scientific Corporation, LivaNova PLC., Lepu Medical Technology Co., Ltd., CryoLife, Inc., Symetis SA, Jenavalve Technology, Inc., Braile Biomédica, Labcor Laboratorios Ltd., ShockWave Medical, Inc., Meril Life Sciences, TTK Healthcare Limited, and others.
Which MedTech key players in the Prosthetic Heart Valves market are set to emerge as the trendsetter explore @ Key Prosthetic Heart Valves Companies
https://www.delveinsight.com/sample-request/prosthetic-heart-valve-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Prosthetic Heart Valves Market Landscape
Furthermore, the increasing number of strategic initiatives and product developments by key players in the prosthetic heart valve market is significantly driving overall market growth. For example, in July 2022, Venus Medtech received approval from China's National Medical Products Administration (NMPA) for its innovative VenusP-ValveTM, a transcatheter pulmonic valve replacement (TPVR) system designed to treat severe pulmonary regurgitation in patients with congenital heart defects (CHD) and a native right ventricular outflow tract (RVOT). The VenusP-ValveTM offers a specialized solution for managing pulmonary valve dysfunction, particularly in CHD cases.
Collectively, such advancements and regulatory approvals are expected to further accelerate the growth of the global prosthetic heart valve market during the forecast period from 2025 to 2032.
Scope of the Prosthetic Heart Valves Market Report
• Coverage: Global
• Study Period: 2022-2032
• Prosthetic Heart Valves Market Segmentation By Product Type: Transcatheter Heart Valves, Bioprosthetic (Tissue) Heart Valves, and Mechanical Heart Valves
• Prosthetic Heart Valves Market Segmentation By Valve Position: Aortic Valve, Mitral Valve, Tricuspid Valve, and Pulmonary Valve
• Prosthetic Heart Valves Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics
• Prosthetic Heart Valves Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Prosthetic Heart Valves Companies: Medtronic plc., Abott., Edwards Lifesciences Corp., Corcym Srl, Boston Scientific Corporation, LivaNova PLC., Lepu Medical Technology Co., Ltd., CryoLife, Inc., Symetis SA, Jenavalve Technology, Inc., Braile Biomédica, Labcor Laboratorios Ltd., ShockWave Medical, Inc., Meril Life Sciences, TTK Healthcare Limited, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Prosthetic Heart Valves market will grow by 2032? Click to get a snapshot of the Prosthetic Heart Valves Market Analysis
https://www.delveinsight.com/sample-request/prosthetic-heart-valve-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Prosthetic Heart Valves Market to grow at a CAGR of 11.86% by 2032, Evaluates DelveInsight here
News-ID: 4243418 • Views: …
More Releases from DelveInsight Business Research
Retinitis Pigmentosa Pipeline 2026: FDA Approvals and Clinical Trials Landscape …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Retinitis Pigmentosa pipeline constitutes 20+ key companies continuously working towards developing 25+ Retinitis Pigmentosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Retinitis Pigmentosa Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Retinitis Pigmentosa Market.
The Retinitis…
Multiple Sclerosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
Car T Cell Therapy For Multiple Myeloma Pipeline 2026: MOA, ROA, FDA-Approved Dr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Car T Cell Therapy For Multiple Myeloma pipeline constitutes 5+ key companies continuously working towards developing 5+ Car T Cell Therapy For Multiple Myeloma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Car T Cell Therapy For Multiple Myeloma Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into…
Spinocerebellar Ataxias Pipeline 2026: Therapies Under Investigation, Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…
More Releases for Valve
Selecting the Right Valve: Knife Gate Valve vs. Wedge Gate Valve
Choosing between a knife gate valve and a wedge gate valve isn't just about picking a piece of metal for your pipeline. It's about preventing costly downtime. Get it wrong, and you are looking at clogged lines, seat erosion, or total system failure. While both valves serve as isolation devices, they operate on completely different mechanical principles.
At Tianjin Guoji Valve Co., Ltd. (widely recognized in the industry as TGV), we…
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;…
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure.
According to Fact.MR’s…
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which…
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn…
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market…
